Cutaneous Eruption due to Telaprevir

Hepatitis C virus (HCV) chronically infects 0.5–3% of the world population. A large group of patients develop cirrhosis and its complications. Since 2011, telaprevir and boceprevir are used, improving the disease evolution. One of the main side effects of these drugs is skin eruption. We report a 53...

Descripción completa

Detalles Bibliográficos
Autores principales: Falcão, Eduardo Mastrangelo Marinho, Trope, Beatriz Moritz, Godinho, Mariana Marteleto, Carneiro, Leonardo Hoehl, de Araujo-Neto, João Marcello, Nogueira, Cristiane Alves Villela, Ramos-e-Silva, Marcia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2015
Materias:
Published online: September, 2015
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612548/
https://www.ncbi.nlm.nih.gov/pubmed/26500538
http://dx.doi.org/10.1159/000439264
_version_ 1782396186472218624
author Falcão, Eduardo Mastrangelo Marinho
Trope, Beatriz Moritz
Godinho, Mariana Marteleto
Carneiro, Leonardo Hoehl
de Araujo-Neto, João Marcello
Nogueira, Cristiane Alves Villela
Ramos-e-Silva, Marcia
author_facet Falcão, Eduardo Mastrangelo Marinho
Trope, Beatriz Moritz
Godinho, Mariana Marteleto
Carneiro, Leonardo Hoehl
de Araujo-Neto, João Marcello
Nogueira, Cristiane Alves Villela
Ramos-e-Silva, Marcia
author_sort Falcão, Eduardo Mastrangelo Marinho
collection PubMed
description Hepatitis C virus (HCV) chronically infects 0.5–3% of the world population. A large group of patients develop cirrhosis and its complications. Since 2011, telaprevir and boceprevir are used, improving the disease evolution. One of the main side effects of these drugs is skin eruption. We report a 53-year-old patient with cirrhosis due to HCV who started the classic treatment associated with telaprevir. In the ninth week, he presented a severe rash that required the interruption of this drug. We emphasize the importance of early recognition and appropriate management of adverse skin reaction.
format Online
Article
Text
id pubmed-4612548
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-46125482015-10-23 Cutaneous Eruption due to Telaprevir Falcão, Eduardo Mastrangelo Marinho Trope, Beatriz Moritz Godinho, Mariana Marteleto Carneiro, Leonardo Hoehl de Araujo-Neto, João Marcello Nogueira, Cristiane Alves Villela Ramos-e-Silva, Marcia Case Rep Dermatol Published online: September, 2015 Hepatitis C virus (HCV) chronically infects 0.5–3% of the world population. A large group of patients develop cirrhosis and its complications. Since 2011, telaprevir and boceprevir are used, improving the disease evolution. One of the main side effects of these drugs is skin eruption. We report a 53-year-old patient with cirrhosis due to HCV who started the classic treatment associated with telaprevir. In the ninth week, he presented a severe rash that required the interruption of this drug. We emphasize the importance of early recognition and appropriate management of adverse skin reaction. S. Karger AG 2015-09-29 /pmc/articles/PMC4612548/ /pubmed/26500538 http://dx.doi.org/10.1159/000439264 Text en Copyright © 2015 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Published online: September, 2015
Falcão, Eduardo Mastrangelo Marinho
Trope, Beatriz Moritz
Godinho, Mariana Marteleto
Carneiro, Leonardo Hoehl
de Araujo-Neto, João Marcello
Nogueira, Cristiane Alves Villela
Ramos-e-Silva, Marcia
Cutaneous Eruption due to Telaprevir
title Cutaneous Eruption due to Telaprevir
title_full Cutaneous Eruption due to Telaprevir
title_fullStr Cutaneous Eruption due to Telaprevir
title_full_unstemmed Cutaneous Eruption due to Telaprevir
title_short Cutaneous Eruption due to Telaprevir
title_sort cutaneous eruption due to telaprevir
topic Published online: September, 2015
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612548/
https://www.ncbi.nlm.nih.gov/pubmed/26500538
http://dx.doi.org/10.1159/000439264
work_keys_str_mv AT falcaoeduardomastrangelomarinho cutaneouseruptionduetotelaprevir
AT tropebeatrizmoritz cutaneouseruptionduetotelaprevir
AT godinhomarianamarteleto cutaneouseruptionduetotelaprevir
AT carneiroleonardohoehl cutaneouseruptionduetotelaprevir
AT dearaujonetojoaomarcello cutaneouseruptionduetotelaprevir
AT nogueiracristianealvesvillela cutaneouseruptionduetotelaprevir
AT ramosesilvamarcia cutaneouseruptionduetotelaprevir

Ejemplares similares